Children’s Cancer and Leukaemia Group (CCLG) has published its first ever report showcasing the impact our research has had on driving forward pioneering breakthroughs into finding a cure for childhood cancer.
A six-year-old boy who has recently finished treatment for rhabdomyosarcoma is set to take part in a special fundraising event in aid of a Children's Cancer and Leukaemia Group (CCLG) Special Named Fund set up in his name.
In a statement released today (Wednesday, March 30), the One Cancer Voice charity coalition, of which Children’s Cancer and Leukaemia Group (CCLG) is a member, has published 10 tests the Government’s new ‘10-year Cancer Plan’ must meet to succeed in delivering world-leading and transformative change.
Children's Cancer and Leukaemia Group (CCLG) hosts its annual Winter Meeting next week (April 4-5), bringing together experts from across the childhood cancer community. The UK's leading children's cancer meeting for professionals returns for a two-day conference of essential updates on...
A family fundraising in memory of their five-year-old son has now raised £250,000 for research into rhabdomyosarcoma. After Jake Ellis passed away from the soft tissue cancer in 2008, his parents, Jo-ann and Nick, set up Team Jake, a Children’s Cancer and Leukaemia Group (CCLG)...
Experts from the University of Nottingham have developed a protocol for clinicians around the world which will help to close the gap between diagnosis and treatment of childhood cancer, and could increase the chance of survival from the disease.
Dr Rachel Cox, is a consultant paediatric oncologist and Chair of CCLG’s Late Effects Group. She tells us what late effects are, and how the work of the group is helping to improve the quality of life for survivors of childhood cancer.
ALLTogether-1 is an international clinical trial looking at improving treatment for acute lymphoblastic leukaemia (ALL). Dr John Moppett, who oversees the trial in the UK, explains more.
Lee Brennan, 48, found fame as the singer of '911' in the late 1990s. He was diagnosed with Hodgkin lymphoma as a 9-year-old, before relapsing aged 15, and he tells us how his cancer experience has influenced a new vocation.
